ELI LILLY, REGENERON AMONG FIRST COMPANIES SELECTED FOR FDA INITIATIVE TO SPEED REVIEW OF NEW MANUFACTURING FACILITIES - CNBC
Reuters
Eli Lilly, Regeneron Among First Companies Selected For FDA Initiative To Speed Review Of New Manufacturing Facilities - CNBC
- Sources
- Reuters
- Markets
- Stocks
- Active symbols
- NASDAQ:REGN, NYSE:LLY
- Language
- English